# Syndax Pharmaceuticals Inc: Form 8-K, filed Jan 12, 2026

- Company: [Syndax Pharmaceuticals Inc](/companies/sndx.md) (CIK 1395937)
- Form: 8-K
- Filed: 2026-01-12
- Accepted by EDGAR: Jan 12, 2026, 16:36 ET
- Period: 2026-01-12
- Accession: 0001193125-26-010486
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1395937/000119312526010486/sndx-20260112.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395937/000119312526010486/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395937/000119312526010486/sndx-20260112.htm

Filed Jan 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-010486. Last ingested by Listed: Nov 2, 2026, 16:31 ET. No prices; not investment advice.